As technology changes the way life science companies research, innovate and make products, clients in this ever-changing industry require a specific and deep understanding of the complex regulation and unique nature of the commercial agreements needed. ZAG possesses this understanding in abundance.
Life science companies trust our proven track record in negotiating technology and IP licensing agreements, including those for companies who have received grants from the Israel Innovation Authority (IAA, also formerly known as the Office of the Chief Scientist). Our comprehensive knowledge also includes strategic agreements, collaboration agreements with academic institutions, clinical trial and distribution agreements, as well as licensing transactions for public companies, and much more.
